Phase II study of sorafenib and pemetrexed after 1st line platinum chemotherapy in advanced stage IIIB malignant effusion or IV non small cell lung cancer

Trial Profile

Phase II study of sorafenib and pemetrexed after 1st line platinum chemotherapy in advanced stage IIIB malignant effusion or IV non small cell lung cancer

Not stated
Phase of Trial: Phase II

Latest Information Update: 04 Jan 2007

At a glance

  • Drugs Pemetrexed; Sorafenib
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Jan 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top